Having worked in a proteomics lab for my PhD dissertation, I had some familiarity with the tools and strategies used to study biology on a systems level. One of the concepts I was always interested in was the ability to just follow a protein's journey throughout the cell, from the time it is translated by the ribosome to its final destination either within an organelle or when it is secreted into the extracellular space. At the time I was finishing up, I wasn't sure that the technology was yet advanced enough to make that a reality, particularly if done within a single cell. But within the past few years, a new era of spatial proteomics has emerged to allow us to observe cell biology in a whole new light.
Reaching the golden years doesn’t always feel so golden. As we age, disease, injury, and other stress factors from the environment will damage our bodies' cells. Most cells may be able to repair that damage, while our immune system usually clears those damaged cells through a process called apoptosis. However, if cellular repair and clearance is not effective, the residual damaged cells will further weaken the immune system and deteriorate other biological processes. Is there a possibility that we can avoid this cellular damage and improve the health of older people? A cellular state known as senescence might hold the key to this question.[1, 2] During senescence, the damaged cells irreversibly stop dividing and resist being removed.  Researchers have shown that determining senescence biomarkers could lead to new therapies for the inflammatory disease caused by senescence in older people.
As we try to come back to some level of normalcy after a couple of long, stressful years of pandemic, science has been continuing to chug along to improve the human condition. In celebration of this, we had silly achievements that made us laugh, then think, in the form of the Ig Nobel prizes, and this week, the cream of the crop was recognized with the three science Nobel Prizes. We wanted to highlight the Physiology and Medicine prize separately since ABclonal is a bioscience reagents company, but as we said before, every field of science is important to the pursuit of not just biological advancement, but the betterment of all humanity. So while you can also read about the achievements of the Medicine winner, Dr. Svante Pääbo, in the previous entry, here are the science prize winners in all the glory we can give them in this blog space!
Open collaboration is important for sustainable science, and every new study or publication, no matter the journal or institution, contributes to a greater understanding of biology, for better or for worse. Dozens of prior discoveries funnel into every new breakthrough, so we need to appreciate the years of painstaking labor and thought that go into every new morsel of knowledge. It is very fulfilling when ABclonal products are part of the fuel that drives these studies in diverse fields of biology. With our ABclonal in Action series, we hope to highlight our products as well as the new insights from our customers all over the globe that will become stepping stones for the next generation of cutting-edge bioscience.
When I was an aspiring (much younger) scientist, one of the challenges was finding quality antibodies to accommodate our research group’s high-throughput Western blotting platform 1 while studying signaling pathways in cancer cell lines. When I got into marketing, I learned about ABclonal’s high-quality, high-specificity, and high-affinity antibody products. I really wish that I had access to these products when I was doing my thesis research! With a team of passionate, capable scientists supporting these quality products, I was thrilled at the opportunity to be part of this company and to help spread ABclonal’s brand to the scientific community.
A Bird’s Eye View of Necroptosis
Necroptosis is a type of regulated necrotic death driven by defined molecular pathways. Regulated necrosis regulates programmed cell death. Necroptosis is at the center of the pathophysiology of several clinically-relevant disease states, including myocardial infarction and stroke, atherosclerosis, ischemia-reperfusion injury, pancreatitis, and inflammatory bowel disease. Necroptosis results in necrosis-like morphological changes, such as cell swelling, plasma membrane pore formation, and membrane rupture. It also requires co-activation of receptor-interacting protein (RIP) 1 and RIP3 kinases. Necrosome is a complex formed by RIP1, RIP3 and Fas-associated proteins with death domain (FADD). Several studies in the preclinical stage have demonstrated that targeting necrosome can have variable effects on progression of tumors, indicating that it is largely cell-type or context dependent.